iCare and Thirona are joining forces in AI solutions
iCare and Dutch Thirona launch a partnership with iCare to distribute Thirona 's Artificial Intelligence in
Thirona is one of the leading and highly respected companies specializing in artificial intelligence for medical image analysis.
”This is an exciting opportunity to contribute to keeping the wonderful world visible for all. Together with Thirona, we are implementing a top-performance screening solution based on fundus images. We start by screening diabetic retinopathy from diabetics and bring to market an integrated service that is fast and easy to use thanks to automation. High-quality images from the iCare DRSplus fundus imaging system provide a good foundation for the solution” says Pirjo Kortteisto, Business Development Manager of Icare Finland.
“By joining forces with iCare we can bring innovation to the mainstream markets faster. iCare is not just a distribution channel for us. Partnerships based on a shared vision and mutual trust are very centric to Thirona’s strategy, so we are happy to have iCare as our strategic partner”, says
For further information, please contact
Pirjo Kortteisto, Business Development Manager
pirjo.kortteisto@revenio.fi
Distribution
Principal media
www.revenio.fi
In 2021, the Group’s net sales totaled
Thirona in brief
Thirona is an innovative company specializing in artificial intelligence for medical image analysis that allow for precise quantification of disease symptoms and contribute to personalized patient treatment. Thirona partners with research institutions and medical companies in their innovation trajectories aimed to enable breakthroughs in treatment development and clinical care. Founded in 2014 by female scientist
RetCAD™, one of Thirona’s brands, is a MDR class IIa certified software using artificial intelligence that analyses color fundus images for the presence of eye diseases. It assists eye care providers in early diagnosis and grading of the vision threatening diseases. RetCAD™ uses state-of-the-art deep learning and computer vision technology, utilizing large amounts of human-specialist graded images, to provide quantified clinical outcome measures.
For more information visit: retcad.thirona.eu
Contact: mediarelations@thirona.eu
© Modular Finance, source